Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group .

Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455. No abstract available.

PMID:
31504418
2.

Harbour porpoise responses to pile-driving diminish over time.

Graham IM, Merchant ND, Farcas A, Barton TR, Cheney B, Bono S, Thompson PM.

R Soc Open Sci. 2019 Jun 26;6(6):190335. doi: 10.1098/rsos.190335. eCollection 2019 Jun.

3.

Fine scale spatial variability in the influence of environmental cycles on the occurrence of dolphins at coastal sites.

Fernandez-Betelu O, Graham IM, Cornulier T, Thompson PM.

Sci Rep. 2019 Feb 22;9(1):2548. doi: 10.1038/s41598-019-38900-4.

4.

Current guidelines on prevention with a focus on dyslipidemias.

Graham IM, Catapano AL, Wong ND.

Cardiovasc Diagn Ther. 2017 Apr;7(Suppl 1):S4-S10. doi: 10.21037/cdt.2017.04.04. Review.

5.

Management of Dyslipidemias in Europe and the USA: Same Evidence, Different Conclusions? Can We Find Common Ground?

Graham IM, Catapano AL.

Curr Cardiol Rep. 2017 Jun;19(6):49. doi: 10.1007/s11886-017-0857-7. Review.

PMID:
28432660
6.

Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries.

Zhao M, Cooney MT, Klipstein-Grobusch K, Vaartjes I, De Bacquer D, De Sutter J, Reiner Ž, Prescott E, Faggiano P, Vanuzzo D, AlFaleh H, Menown IB, Gait D, Posogova N, Sheu WH, Zhao D, Zuo H, Grobbee DE, Graham IM.

Eur J Prev Cardiol. 2016 Jul;23(11):1202-10. doi: 10.1177/2047487316647827. Epub 2016 Apr 26.

PMID:
27118362
7.

Validating the use of intrinsic markers in body feathers to identify inter-individual differences in non-breeding areas of northern fulmars.

Quinn LR, Meharg AA, van Franeker JA, Graham IM, Thompson PM.

Mar Biol. 2016;163:64. Epub 2016 Feb 29.

8.

Evaluating adaptive co-management as conservation conflict resolution: Learning from seals and salmon.

Butler JR, Young JC, McMyn IA, Leyshon B, Graham IM, Walker I, Baxter JM, Dodd J, Warburton C.

J Environ Manage. 2015 Sep 1;160:212-25. doi: 10.1016/j.jenvman.2015.06.019. Epub 2015 Jul 2.

9.

Cardiovascular risk estimation in older persons: SCORE O.P.

Cooney MT, Selmer R, Lindman A, Tverdal A, Menotti A, Thomsen T, DeBacker G, De Bacquer D, Tell GS, Njolstad I, Graham IM; SCORE and CONOR investigators.

Eur J Prev Cardiol. 2016 Jul;23(10):1093-103. doi: 10.1177/2047487315588390. Epub 2015 Jun 3.

PMID:
26040999
10.

Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials.

Sahebkar A, Serban C, Ursoniu S, Wong ND, Muntner P, Graham IM, Mikhailidis DP, Rizzo M, Rysz J, Sperling LS, Lip GY, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration Group.

Int J Cardiol. 2015;189:47-55. doi: 10.1016/j.ijcard.2015.04.008. Epub 2015 Apr 1. Review.

PMID:
25885871
11.

Variation in harbour porpoise activity in response to seismic survey noise.

Pirotta E, Brookes KL, Graham IM, Thompson PM.

Biol Lett. 2014 May;10(5):20131090. doi: 10.1098/rsbl.2013.1090.

12.

Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.

Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, Ikram MA, Stricker BH, Hofman A, Franco OH.

JAMA. 2014 Apr 9;311(14):1416-23. doi: 10.1001/jama.2014.2632.

13.

A comparison of the herbicide tolerances of rare and common plants in an agricultural landscape.

Egan JF, Graham IM, Mortensen DA.

Environ Toxicol Chem. 2014 Mar;33(3):696-702. doi: 10.1002/etc.2491. Epub 2014 Jan 31.

PMID:
24488525
14.

Risks in estimating risk.

Graham IM, Cooney MT.

Eur Heart J. 2014 Mar;35(9):537-9. doi: 10.1093/eurheartj/eht286. Epub 2013 Nov 7. No abstract available.

PMID:
24204012
15.

Short-term disturbance by a commercial two-dimensional seismic survey does not lead to long-term displacement of harbour porpoises.

Thompson PM, Brookes KL, Graham IM, Barton TR, Needham K, Bradbury G, Merchant ND.

Proc Biol Sci. 2013 Oct 2;280(1771):20132001. doi: 10.1098/rspb.2013.2001. Print 2013 Nov 22.

16.

Total cardiovascular disease risk assessment: a review.

Cooney MT, Cooney HC, Dudina A, Graham IM.

Curr Opin Cardiol. 2011 Sep;26(5):429-37. doi: 10.1097/HCO.0b013e3283499f06. Review.

PMID:
21822139
17.

Exercise induced fatigue: unfit or unwell?

Moore DM, Nadarajan P, Hawksworth R, Lane SJ, Graham IM.

Ir Med J. 2011 May;104(5):151.

PMID:
21736093
18.

The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteins.

Elshorbagy AK, Valdivia-Garcia M, Graham IM, Palma Reis R, Sales Luis A, Smith AD, Refsum H.

Nutr Metab Cardiovasc Dis. 2012 Dec;22(12):1031-8. doi: 10.1016/j.numecd.2011.01.008. Epub 2011 May 6.

PMID:
21550220
19.

Diagnosing coronary artery disease--the Diamond and Forrester model revisited.

Graham IM.

Eur Heart J. 2011 Jun;32(11):1311-2. doi: 10.1093/eurheartj/ehr015. Epub 2011 Mar 11. No abstract available.

PMID:
21398309
20.

Medication details documented on hospital discharge: cross-sectional observational study of factors associated with medication non-reconciliation.

Grimes TC, Duggan CA, Delaney TP, Graham IM, Conlon KC, Deasy E, Jago-Byrne MC, O' Brien P.

Br J Clin Pharmacol. 2011 Mar;71(3):449-57. doi: 10.1111/j.1365-2125.2010.03834.x.

21.

Integrin α(IIb)β₃ exists in an activated state in subjects with elevated plasma homocysteine levels.

McGarrigle SA, O'Neill S, Walsh GM, Moran N, Graham IM, Cooney MT, Monavari A, Mayne P, Collins P.

Platelets. 2011;22(1):65-73. doi: 10.3109/09537104.2010.512646. Epub 2010 Dec 6.

PMID:
21133649
22.

Assessment of cardiovascular risk.

Cooney MT, Cooney HC, Dudina A, Graham IM.

Curr Hypertens Rep. 2010 Oct;12(5):384-93. doi: 10.1007/s11906-010-0143-1. Review.

PMID:
20838940
23.

Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?

Cooney MT, Dudina A, D'Agostino R, Graham IM.

Circulation. 2010 Jul 20;122(3):300-10. doi: 10.1161/CIRCULATIONAHA.109.852756. Review. No abstract available.

PMID:
20644026
24.

Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study.

Tobin AM, Hughes R, Hand EB, Leong T, Graham IM, Kirby B.

Clin Exp Dermatol. 2011 Jan;36(1):19-23. doi: 10.1111/j.1365-2230.2010.03877.x.

PMID:
20545954
25.

Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women.

Cooney MT, Vartiainen E, Laatikainen T, Juolevi A, Dudina A, Graham IM.

Am Heart J. 2010 Apr;159(4):612-619.e3. doi: 10.1016/j.ahj.2009.12.029. Erratum in: Am Heart J. 2010 Jul;160(1):208. Laakitainen, Tinna [corrected to Laatikainen, Tiina].

PMID:
20362720
26.

Italian cardiovascular mortality charts of the CUORE project: are they comparable with the SCORE charts?

Donfrancesco C, Palmieri L, Cooney MT, Vanuzzo D, Panico S, Cesana G, Ferrario M, Pilotto L, Graham IM, Giampaoli S.

Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):403-9. doi: 10.1097/HJR.0b013e328334ea70.

PMID:
20351552
27.

Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

Cooney MT, Dudina AL, Graham IM.

J Am Coll Cardiol. 2009 Sep 29;54(14):1209-27. doi: 10.1016/j.jacc.2009.07.020. Review.

28.

What is my risk of developing cardiovascular disease?

Graham IM, Cooney MT, Dudina A, Squarta S.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S2-7. doi: 10.1097/01.hjr.0000359226.50399.59. No abstract available.

PMID:
19675432
29.

Dyslipidemia therapy update: the importance of full lipid profile assessment.

Menown IB, Murtagh G, Maher V, Cooney MT, Graham IM, Tomkin G.

Adv Ther. 2009 Jul;26(7):711-8. doi: 10.1007/s12325-009-0052-3. Epub 2009 Jul 27. Review.

PMID:
19649582
30.

Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.

Atella V, Brady A, Catapano AL, Critchley J, Graham IM, Hobbs FD, Leal J, Lindgren P, Vanuzzo D, Volpe M, Wood D, Paoletti R.

Atheroscler Suppl. 2009 Jun 10;10(1):3-21. doi: 10.1016/S1567-5688(09)70003-0.

PMID:
19497553
31.

HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk.

Cooney MT, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham IM; SCORE investigators.

Atherosclerosis. 2009 Oct;206(2):611-6. doi: 10.1016/j.atherosclerosis.2009.02.041. Epub 2009 Mar 19.

PMID:
19375079
32.

Homocysteine increases the risk associated with hyperlipidaemia.

Daly C, Fitzgerald AP, O'Callaghan P, Collins P, Cooney MT, Graham IM; COMAC Group.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):150-5. doi: 10.1097/HJR.0b013e32831e1185.

PMID:
19276985
33.

The association of plasma cysteine and gamma-glutamyltransferase with BMI and obesity.

Elshorbagy AK, Refsum H, Smith AD, Graham IM.

Obesity (Silver Spring). 2009 Jul;17(7):1435-40. doi: 10.1038/oby.2008.671. Epub 2009 Feb 12.

34.

Chest pain and hypertension in an 18 year old girl.

Dudina AL, Moore DP, Keogh B, Foley D, Graham IM.

Ir Med J. 2008 Oct;101(9):285-6.

PMID:
19051620
35.

Survey of medication documentation at hospital discharge: implications for patient safety and continuity of care.

Grimes T, Delaney T, Duggan C, Kelly JG, Graham IM.

Ir J Med Sci. 2008 Jun;177(2):93-7. doi: 10.1007/s11845-008-0142-2. Epub 2008 Apr 15.

PMID:
18414970
36.

von Willebrand Factor in CHD and stroke: relationships and therapeutic implications.

Cooney MT, Dudina AL, O'Callaghan P, Graham IM.

Curr Treat Options Cardiovasc Med. 2007 Jun;9(3):180-90.

PMID:
17601381
37.

The importance of total cardiovascular risk assessment in clinical practice.

Graham IM.

Eur J Gen Pract. 2006;12(4):148-55. Review.

PMID:
17127600
38.

Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology.

Graham IM, Stewart M, Hertog MG; Cardiovascular Round Table Task Force.

Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):839-45.

PMID:
17001227
39.

New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers.

O'Callaghan PA, Fitzgerald A, Fogarty J, Gaffney P, Hanbidge M, Boran G, Enright H, Murphy J, McCarthy B, Graham IM.

Eur J Cardiovasc Prev Rehabil. 2005 Dec;12(6):542-7.

PMID:
16319543
40.

Whither cardiovascular risk prediction?

Graham IM, Leong T.

Eur J Cardiovasc Prev Rehabil. 2005 Oct;12(5):421-3. No abstract available.

PMID:
16210926
41.

Guidelines on cardiovascular disease prevention in clinical practice: the European perspective.

Graham IM.

Curr Opin Cardiol. 2005 Sep;20(5):430-9. Review.

PMID:
16093763
42.

Disease dynamics in cyclic populations of field voles (Microtus agrestis): cowpox virus and vole tuberculosis (Mycobacterium microti).

Cavanagh RD, Lambin X, Ergon T, Bennett M, Graham IM, van Soolingen D, Begon M.

Proc Biol Sci. 2004 Apr 22;271(1541):859-67.

43.

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE project group.

Eur Heart J. 2003 Jun;24(11):987-1003.

PMID:
12788299
44.

Vitamins, homocysteine and cardiovascular risk.

Graham IM, O'Callaghan P.

Cardiovasc Drugs Ther. 2002 Sep;16(5):383-9. Review.

PMID:
12652107
45.

Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project.

Meleady R, Ueland PM, Blom H, Whitehead AS, Refsum H, Daly LE, Vollset SE, Donohue C, Giesendorf B, Graham IM, Ulvik A, Zhang Y, Bjorke Monsen AL; EC Concerted Action Project: Homocysteine and Vascular Disease.

Am J Clin Nutr. 2003 Jan;77(1):63-70.

PMID:
12499324
46.

Mycobacterium microti infection (vole tuberculosis) in wild rodent populations.

Cavanagh R, Begon M, Bennett M, Ergon T, Graham IM, De Haas PE, Hart CA, Koedam M, Kremer K, Lambin X, Roholl P, Soolingen Dv Dv.

J Clin Microbiol. 2002 Sep;40(9):3281-5.

47.

Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project.

El-Khairy L, Ueland PM, Refsum H, Graham IM, Vollset SE; European Concerted Action Project.

Circulation. 2001 May 29;103(21):2544-9.

PMID:
11382721
48.

Thermolabile MTHFR genotype and retinal vascular occlusive disease.

Cahill M, Karabatzaki M, Donoghue C, Meleady R, Mynett-Johnson LA, Mooney D, Graham IM, Whitehead AS, Shields DC.

Br J Ophthalmol. 2001 Jan;85(1):88-90.

49.

The role of folic acid in the prevention of cardiovascular disease.

Graham IM, O'Callaghan P.

Curr Opin Lipidol. 2000 Dec;11(6):577-87. Review.

PMID:
11086330
50.

Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes.

Stubbs PJ, Al-Obaidi MK, Conroy RM, Collinson PO, Graham IM, Noble IM.

Circulation. 2000 Aug 8;102(6):605-10.

PMID:
10931798

Supplemental Content

Loading ...
Support Center